Laure Elkrief

Université de Tours Faculté de Médecine

France

Research Interests

Explore related searches

Professors in France

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (6)

Pierre‐Emmanuel Rautou

FRANCE

View details

Xavier Verhelst

Associate Professor of Hepatology

Ghent University

BELGIUM

View details

ANGELA PUENTE

Marqués de Valdecilla University Hospital

SPAIN

View details

Rafael Bañares

Full Professor

Universidad Complutense de Madrid

SPAIN

View details

Andrea De Gottardi

SWITZERLAND

View details

Jose Ignacio Fortea

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Laure Elkrief

Research Interests

Explore related searches

Contact this professor

Articles (10)

Variation of the SOFA score and mortality in patients with severe burns: A cohort study

Liver Transplantation for Porto-Sinusoidal Vascular Liver Disorder: Long-term Outcome.

Cannabis use as a factor of lower corpulence in hepatitis C-infected patients: results from the ANRS CO22 Hepather cohort

Low alcohol consumption influences outcomes in individuals with alcohol-related compensated cirrhosis in a French multicenter cohort

Cannabis Use Is Inversely Associated with Overweight and Obesity in Hepatitis B Virus-Infected Patients (ANRS CO22 Hepather Cohort)

Impact of the presence of median arcuate ligament on biliary complications after liver transplantation

Contrast‐enhanced CT and liver surface nodularity for the diagnosis of porto‐sinusoidal vascular disorder: A case‐control study

Paroxysmal nocturnal hemoglobinuria and vascular liver disease: Eculizumab therapy decreases mortality and thrombotic complications

Non-invasive diagnosis and follow-up of vascular liver diseases

Systemic Treatments with Tyrosine Kinase Inhibitor and Platinum-Based Chemotherapy in Patients with Unresectable or Metastatic Hepatocholangiocarcinoma

Collaborators (6)

Pierre‐Emmanuel Rautou

Xavier Verhelst

ANGELA PUENTE

Rafael Bañares

Andrea De Gottardi

Jose Ignacio Fortea

Make your next move.